z-logo
open-access-imgOpen Access
BRCA1 Versus BRCA2 and PARP Inhibitor Sensitivity in Prostate Cancer: More Different Than Alike?
Author(s) -
Mark C. Markowski,
Emmanuel S. Antonarakis
Publication year - 2020
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.20.02246
Subject(s) - medicine , prostate cancer , parp inhibitor , oncology , prostate , cancer research , cancer , poly adp ribose polymerase , genetics , dna , biology , polymerase

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom